Conception and design: Gabrielle B. Rocque, Mary Lou Smith, Lynne I. Wagner, Nadine Tung, Antonio C. Wolff

Financial support: Gabrielle B. Rocque

Administrative support: Gabrielle B. Rocque, Stacey A. Ingram

Collection and assembly of data: Gabrielle B. Rocque, Valerie M. Lawhon, Stacey A. Ingram

Data analysis and interpretation: Gabrielle B. Rocque, Courtney Andrews, Rachel Frazier, Lynne I. Wagner, Lisa Zubkoff, Lauren P. Wallner, Antonio C. Wolff

Manuscript writing: All authors

Final approval of manuscript: All authors

Accountable for all aspects of the work: All authors

AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST

Oncologist-Reported Barriers and Facilitators to Enrolling Patients in Optimization Trials that Test Less Intense Cancer Treatment

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/op/authors/author-center.

Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).

Gabrielle B. Rocque

This author is an Associate Editor of JCO Oncology Practice. Journal policy recused the author from having any role in the peer review of this manuscript.

Consulting or Advisory Role: Pfizer, Flatiron Health, Gilead Sciences

Research Funding: Carevive Systems, Genentech, Pfizer

Travel, Accommodations, Expenses: Gilead Sciences

Mary Lou Smith

Consulting or Advisory Role: Novartis, Pfizer, Bayer (Inst)

Research Funding: Genentech (Inst), Novartis (Inst), Foundation Medicine (Inst), Exact Sciences, Pfizer, Seagan (Inst)

Lynne I. Wagner

Consulting or Advisory Role: Celgene, Athenex

Travel, Accommodations, Expenses: Celgene

Nadine Tung

Consulting or Advisory Role: AstraZeneca

Research Funding: AstraZeneca (Inst)

Lauren P. Wallner

Honoraria: Kaiser Permanente

Consulting or Advisory Role: Gilead Sciences

Travel, Accommodations, Expenses: Gilead Sciences

Antonio C. Wolff

Research Funding: Genentech (Inst), Merck Sharp & Dohme (Inst), Array Biopharma, Inc (Inst)

Patents, Royalties, Other Intellectual Property: A.C.W. has been named as an inventor on one or more issued patents or pending patent applications related to methylation in breast cancer, has assigned his rights to JHU, and participates in a royalty sharing agreement with JHU

No other potential conflicts of interest were reported.